Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

0.56 

0.01 1.8%

as of Nov 27 '22

52 Week Range:

0.44 0.64


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, and hospital management and consulting services in the People's Republic of China. The ocmapny operates in three segments: Self-Owned Hospitals, Invest-Operate-Transfer/Operate-Transfer Hospitals, and Others. It also offers group purchasing organization and other hospital-derived services. In addition, the company manages and operates third-party hospitals and clinics under the invest-operate-transfer model. Further, it sells pharmaceuticals, medical devices, and medical consumables and equipment. The company was formerly known as China Resources Phoenix Healthcare Holdings Company Limited and changed its name to China Resources Medical Holdings Company Limited in October 2018. China Resources Medical Holdings Company Limited was founded in 2007 and is headquartered in Beijing, the People's Republic of China.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 0.07
0.27
0.29
0.20
0.53
0.54
0.56
0.57
0.66
growth rate 285.7% 7.4% -31.0% 165.0% 1.9% 3.7% 1.8% 15.8%
Earnings BIT 138.56
212.12
179.66
234.57
456.57
533.25
508.72
278.11
367.68
growth rate 53.1% -15.3% 30.6% 94.6% 16.8% -4.6% -45.3% 32.2%
Avg.PE 34.47
35.35
20.19
19.40
14.43
14.43
14.43
growth rate 2.6% -42.9% -3.9% -25.6% 0.0% 0.0%
ROA 9.90
5.72
11.12
7.83
-34.63
6.30
6.05
5.15
3.68
4.30
growth rate -42.2% 94.4% -29.6% -100.0% 100.0% -4.0% -14.9% -28.5% 16.9%
ROE 20.83
8.56
14.18
9.90
-43.14
7.86
7.78
6.80
5.16
6.66
growth rate -58.9% 65.7% -30.2% -100.0% 100.0% -1.0% -12.6% -24.1% 29.1%
ROIC 14.63
9.22
11.20
7.90
-43.96
6.90
6.57
5.62
3.92
4.95
growth rate -37.0% 21.5% -29.5% -100.0% 100.0% -4.8% -14.5% -30.3% 26.3%
Cur. Ratio 1.80
3.66
4.72
3.32
2.20
2.16
1.98
2.31
1.88
1.14
growth rate 103.3% 29.0% -29.7% -33.7% -1.8% -8.3% 16.7% -18.6% -39.4%
Quick Ratio 1.58
3.55
4.55
3.14
2.10
2.10
1.90
2.25
1.77
1.04
growth rate 124.7% 28.2% -31.0% -33.1% 0.0% -9.5% 18.4% -21.3% -41.2%
Leverage 2.10
1.31
1.24
1.29
1.23
1.26
1.31
1.33
1.47
1.62
growth rate -37.6% -5.3% 4.0% -4.7% 2.4% 4.0% 1.5% 10.5% 10.2%
Balance Sheet Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 151.87
174.32
212.02
393.15
457.97
534.19
657.77
701.08
879.63
growth rate 14.8% 21.6% 85.4% 16.5% 16.6% 23.1% 6.6% 25.5%
Acct.Payable 123.89
171.87
209.54
245.91
264.03
226.92
243.44
657.49
947.71
growth rate 38.7% 21.9% 17.4% 7.4% -14.1% 7.3% 170.1% 44.1%
Cur.Assets 1,473.42
1,292.80
1,293.87
1,654.36
2,113.87
2,533.23
3,198.21
4,146.89
3,924.58
growth rate -12.3% 0.1% 27.9% 27.8% 19.8% 26.3% 29.7% -5.4%
Total Assets 2,124.04
2,011.91
2,255.47
6,448.34
6,914.20
7,319.48
7,873.98
8,963.19
10,467.60
growth rate -5.3% 12.1% 185.9% 7.2% 5.9% 7.6% 13.8% 16.8%
Cash 401.77
611.54
821.86
1,069.47
877.05
1,524.18
2,006.22
2,701.37
2,324.05
growth rate 52.2% 34.4% 30.1% -18.0% 73.8% 31.6% 34.7% -14.0%
Inventory 31.05
33.83
42.32
50.24
38.60
77.89
62.12
142.04
185.08
growth rate 9.0% 25.1% 18.7% -23.2% 101.8% -20.2% 128.6% 30.3%
Cur.Liabilities 402.92
273.44
389.81
752.35
976.61
1,277.27
1,384.26
2,207.19
3,443.73
growth rate -32.1% 42.6% 93.0% 29.8% 30.8% 8.4% 59.5% 56.0%
Liabilities 408.18
276.66
392.74
1,090.81
1,312.63
1,609.66
1,733.81
2,622.74
3,621.16
growth rate -32.2% 42.0% 177.7% 20.3% 22.6% 7.7% 51.3% 38.1%
Equity 1,617.20
1,627.11
1,747.88
5,238.38
5,481.73
5,589.50
5,903.70
6,105.46
6,450.78
growth rate 0.6% 7.4% 199.7% 4.7% 2.0% 5.6% 3.4% 5.7%
Common Shares 834.00
576.00
831.00
819.00
902.00
1,280.00
0.27
0.27
0.27
0.27
growth rate -30.9% 44.3% -1.4% 10.1% 41.9% -100.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 21.29
36.26
32.17
42.45
34.50
57.61
36.37
209.55
198.43
growth rate 70.3% -11.3% 32.0% -18.7% 67.0% -36.9% 476.2% -5.3%
Cash Dividends 44.46
44.46
32.51
0.54
69.93
118.57
131.49
115.09
91.08
growth rate 0.0% -26.9% -98.3% 12,874.8% 69.5% 10.9% -12.5% -20.9%
Cash From OA 169.68
274.21
231.70
223.79
459.54
334.15
366.05
643.69
710.43
growth rate 61.6% -15.5% -3.4% 105.4% -27.3% 9.6% 75.9% 10.4%
FCF per Share 0.02
0.03
0.04
0.03
0.03
0.04
0.02
0.05
0.03
growth rate 50.0% 33.3% -25.0% 0.0% 33.3% -50.0% 150.0% -40.0%
Sale Purchase of Stock 1,448.73
41.90
41.90
0.46
growth rate -97.1% 0.0% -98.9%
FCF 138.00
148.00
238.00
200.00
181.00
425.00
277.00
330.00
426.00
483.00
growth rate 7.3% 60.8% -16.0% -9.5% 134.8% -34.8% 19.1% 29.1% 13.4%
Income Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 887.35
1,206.27
1,372.27
1,532.83
1,877.72
2,059.48
2,115.32
2,750.65
4,447.48
growth rate 35.9% 13.8% 11.7% 22.5% 9.7% 2.7% 30.0% 61.7%
Op.Income 138.56
212.12
179.66
234.57
456.57
533.25
508.72
278.11
367.68
growth rate 53.1% -15.3% 30.6% 94.6% 16.8% -4.6% -45.3% 32.2%
IBT 143.01
316.76
247.97
-1,452.48
559.51
588.94
541.30
418.19
270.48
growth rate 121.5% -21.7% -100.0% 100.0% 5.3% -8.1% -22.7% -35.3%
Net Income 89.99
230.05
167.05
-1,506.96
421.03
430.90
390.87
310.13
417.92
growth rate 155.6% -27.4% -100.0% 100.0% 2.3% -9.3% -20.7% 34.8%
EPS 0.12
0.16
0.28
0.20
-1.67
0.33
0.34
0.31
0.25
0.33
growth rate 33.3% 75.0% -28.6% -100.0% 100.0% 3.0% -8.8% -19.4% 32.0%
Gross Profit 212.69
297.70
329.58
406.63
668.24
756.68
762.29
636.51
933.56
growth rate 40.0% 10.7% 23.4% 64.3% 13.2% 0.7% -16.5% 46.7%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT 98.87
84.97
84.97
110.89
110.89
growth rate -14.1% 0.0% 30.5% 0.0%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 912.55
879.63
879.63
1,127.91
1,127.91
growth rate -3.6% 0.0% 28.2% 0.0%
Acct.Payable 694.97
947.71
947.71
1,033.62
1,033.62
growth rate 36.4% 0.0% 9.1% 0.0%
Cur.Assets 3,806.71
3,924.58
3,924.58
4,154.82
4,154.82
growth rate 3.1% 0.0% 5.9% 0.0%
Total Assets 10,326.51
10,467.60
10,467.60
10,863.36
10,863.36
growth rate 1.4% 0.0% 3.8% 0.0%
Cash 1,486.92
2,324.05
2,324.05
2,343.45
2,343.45
growth rate 56.3% 0.0% 0.8% 0.0%
Inventory 145.75
185.08
185.08
178.56
178.56
growth rate 27.0% 0.0% -3.5% 0.0%
Cur.Liabilities 3,239.74
3,443.73
3,443.73
2,672.21
2,672.21
growth rate 6.3% 0.0% -22.4% 0.0%
Liabilities 3,705.92
3,621.16
3,621.16
3,795.22
3,795.22
growth rate -2.3% 0.0% 4.8% 0.0%
LT Debt 940.71
940.71
growth rate 0.0%
Equity 6,219.85
6,450.78
6,450.78
6,524.97
6,524.97
growth rate 3.7% 0.0% 1.2% 0.0%
Common Shares 0.27
0.27
0.27
0.27
0.27
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 37.16
62.05
62.05
47.12
47.12
growth rate 67.0% 0.0% -24.1% 0.0%
Cash Dividends 45.54
growth rate
Cash From OA 63.70
291.51
291.51
19.30
19.30
growth rate 357.6% 0.0% -93.4% 0.0%
FCF 26.54
229.46
229.46
-27.82
-27.82
growth rate 764.6% 0.0% -100.0% 0.0%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Sales 886.06
1,337.68
1,337.68
1,425.24
1,425.24
growth rate 51.0% 0.0% 6.6% 0.0%
Op.Income 98.87
84.97
84.97
110.89
110.89
growth rate -14.1% 0.0% 30.5% 0.0%
IBT 135.07
0.17
0.17
127.09
127.09
growth rate -99.9% 0.0% 76,228.8% 0.0%
Net Income 99.66
109.30
109.30
100.79
100.79
growth rate 9.7% 0.0% -7.8% 0.0%
Gross Profit 197.29
269.49
269.49
262.13
262.13
growth rate 36.6% 0.0% -2.7% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (72.83)

YOY Growth Grade:

D (43.41)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 17.19 17.50
EPS / Growth 0.03

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.1% 11.1% 11.1%
Future PE 0.01 13.10 13.10
Future EPS 0.09 0.09 0.09
Value Price
MOS %
0.00
-100.0%
0.30
-47.2%
0.30
-47.2%
MOS Price 0.00 0.15 0.15
IRT 9.61 9.61 9.61

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.